AURORA 1 reports efficacy of voclosporin in lupus nephritis

被引：3
|
作者：
Moroni, Gabriella [1 ,2 ]
Ponticelli, Claudio [3 ]
机构：
[1] Humanitas Univ, Dept Biomed Sci, Milan, Italy
[2] IRCCS Humanitas Res Hosp, Milan, Italy
[3] IRCCS Osped Maggiore Policlin, Nephrol, Milan, Italy
来源：
NATURE REVIEWS NEPHROLOGY | 2021年 / 17卷 / 10期
关键词：
CYCLOSPORINE;
D O I：
10.1038/s41581-021-00460-0
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
The AURORA 1 study reports that low-dose voclosporin added to standard immunosuppressive treatment improved rate of remission in patients with lupus nephritis. Further studies are needed to investigate the long-term efficacy and tolerability of voclosporin and to compare the effects of this treatment with those of low doses of tacrolimus or ciclosporin.
引用
收藏
页码：637 / 638
页数：2
相关论文
共 50 条
  • [31] Update on the Efficacy and Safety Profile of Voclosporin: An Integrated Analysis of Clinical Trials in Lupus Nephritis
    Arriens, Cristina
    Teng, Y. K. Onno
    Ginzler, Ellen M.
    Parikh, Samir V.
    Askanase, Anca D.
    Saxena, Amit
    Gibson, Keisha
    Caster, Dawn J.
    Atsumi, Tatsuya
    Lisk, Laura
    Randhawa, Simrat
    Gluck, Rashieda
    Solomons, Neil
    Huizinga, Robert B.
    ARTHRITIS CARE & RESEARCH, 2023, 75 (07) : 1399 - 1408
  • [32] AURORA PHASE 3 TRIAL DEMONSTRATES VOCLOSPORIN STATISTICAL SUPERIORITY OVER STANDARD OF CARE IN LUPUS NEPHRITIS (LN)
    Gibson, Keisha
    Parikh, Samir
    Saxena, Amit
    Solomons, Neil
    Randhawa, Simrat
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2020, 75 (05) : 819 - 819
  • [33] AURORA PHASE 3 TRIAL DEMONSTRATES VOCLOSPORIN STATISTICAL SUPERIORITY OVER STANDARD OF CARE IN LUPUS NEPHRITIS (LN)
    Caster, Dawn J.
    Solomons, Neil
    Randhawa, Simrat
    Huizinga, Robert B.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 119 - 119
  • [34] Long-term Safety and Efficacy of Voclosporin in Hispanic and Latino Patients with Lupus Nephritis
    Ginzler, Ellen M.
    Saxena, Amit
    Bal, Victoria
    Birardi, Vanessa
    Leher, Henry
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 710 - 712
  • [35] Voclosporin: a novel calcineurin inhibitor for the management of lupus nephritis
    Mejia-Vilet, Juan M.
    Romero-Diaz, Juanita
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2021, 17 (09) : 937 - 945
  • [36] Voclosporin: A Novel Calcineurin Inhibitor for the Treatment of Lupus Nephritis
    McArn, Ann C.
    Nixon, Alexander R.
    Jarrell, Katherine L.
    ANNALS OF PHARMACOTHERAPY, 2022, 56 (11) : 1267 - 1274
  • [37] TRIAL IN PROGRESS: VOCLOSPORIN IN ADOLESCENTS WITH LUPUS NEPHRITIS (VOCAL)
    Waddingham, Nicola
    Rosales, Amber
    Cheung, Gigi
    Potter, Blake
    Palmen, Mary
    Collins, Christopher
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2023, 81 (04) : S90 - S90
  • [38] AURION STUDY: PRELIMINARY RESULTS OF VOCLOSPORIN IN LUPUS NEPHRITIS
    Yahya, R.
    Gafor, A. H. B. A.
    Huizinga, R.
    Chan, T. M.
    Solomons, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1049 - 1050
  • [39] Journal Club: Efficacy and Safety of Voclosporin Versus Placebo for Lupus Nephritis (AURORA 1): A Double-Blind, Randomized, Multicenter, Placebo-Controlled, Phase 3 Trial
    Rubio, Jose
    Kyttaris, Vasileios
    ACR OPEN RHEUMATOLOGY, 2021, 3 (12) : 827 - 831
  • [40] Voclosporin: a novel calcineurin inhibitor for the treatment of lupus nephritis
    van Gelder, Teun
    Lerma, Edgar
    Engelke, Kory
    Huizinga, Robert B.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2022, 15 (05) : 515 - 529
12345